Series B · Medtech & Devices · Grenoble, France · Founded 2016 · 30–40 employees
Remedee Labs has developed the first personal endorphin stimulator using millimeter wave technology for chronic pain management. The French startup's patented MEET (Microelectronic Endorphin Trigger) module is integrated into a wearable bracelet that stimulates natural endorphin production without medication. The company has raised €25.8M across three funding rounds and achieved significant clinical validation, becoming the first CE-certified medical device for fibromyalgia treatment in Europe. Their technology addresses a massive market of 12 million chronic pain sufferers in France alone, with 70% currently receiving inadequate treatment.
No open roles listed right now.